Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
30 October 2025 | Story Anthony Mthembu | Photo Supplied
Prof Liezel Lues
Prof Liezel Lues, the newly elected President of the International Association of Schools and Institutes of Administration (IASIA).

Prof Liezel Lues, Professor in the Department of Public Administration and Management at the University of the Free State (UFS), has been elected as the President of the International Association of Schools and Institutes of Administration (IASIA)

The election took place on 14 October 2025 in Mexico City during the IASIA Board of Management meeting, where Prof Lues received an overwhelming 22 out of 25 votes. Describing her appointment as the pinnacle of her public service career, she reflected.

“It is a moment where hard work, dedication, and unwavering focus have truly converged, and I am deeply grateful to all those who have supported my growth and opened doors along the way.”   

Prof Lues, whose term will run until 2028, was nominated by former IASIA President Dr Najat Zarrouk and endorsed by Prof Ing. Juraj Nemec, Chairperson of the International Commission on Accreditation of Public Administration (ICAPA). 

 

Leading global collaboration in public administration 

As IASIA President, Prof Lues will provide leadership and strategic direction for the association's affairs, overseeing 127 international organisations across 56 countries. Her responsibilities include appointing - subject to the approval of the incoming Board of Management - seven Vice-Presidents representing each global region: Africa, Latin America and the Caribbean, the Middle East, Asia, Europe, North America, and Australia. 

In addition to these duties, she will be travelling extensively to strengthen global partnerships and advance IASIA’s mission of promoting excellence in public administration education and practice. 

 

A vision for a forward-looking IASIA

Prof Lues shared that her motivation to accept this leadership role stems from a desire to contribute strategically to global collaboration and research - particularly in empowering women in academia and public service.

“As a woman in academia and leadership, I was motivated by the need to model representation and inspire others to step into leadership spaces traditionally dominated by men,’’ she explained.  

Looking ahead, she envisions steering IASIA towards a more agile, forward-looking institution. Her priorities for the next three years include: 

  • Promoting and maintaining a collegial and collaborative organisational culture;
  • Embracing digital transformation and innovation;
  • Fostering cross-disciplinary, impactful research; and
  • Investing in sustainable institutional development and rehabilitation strategies. 

Drawing from her extensive experience - first in government and later in academia - Prof Lues expressed confidence in her ability to lead the association into a new era.  

“I am confident that my vision will build on the association's previous successes and elevate it to new horizons in the coming terms,” she said. 

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept